Start typing to retrieve search suggestions. When suggestions are available use up and down arrows to review and ENTER to select. Continue typing to refine.
Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
Trusted Information Creator
Certified November 2025
{arrow_up} Back to top

Litfulo 50mg Hard Capsules {equilateral_black_triangle}

Active Ingredient:
ritlecitinib tosylate
Company:  
Pfizer Limited See contact details
ATC code: 
L04AF08
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Litfulo (ritlecitinib) Patient Card

{healthcare_pro_orange} For Healthcare Professionals

Litfulo RMM Patient Card (Digital) (PP-LGF-GBR-0426)

{pdf_link}

Litfulo (ritlecitinib) Prescriber Guide

{healthcare_pro_orange} For Healthcare Professionals

The RMM is a required material to support the prescribing of Litfulo, the RMM highlights key safety information that HCPs should be aware of when prescribing Litfulo.

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Pfizer Limited
Company image
Address
Ramsgate Road, Sandwich, Kent, CT13 9NJ
Telephone
+44 (0)1304 616 161
Medical Information Website
www.pfizermedicalinformation.co.uk
Medical Information Direct Line
+44 (0)1304 616161